Krida Jaringan Nusantara Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Krida Jaringan Nusantara Tbk trades at Rp122 (market cap 61.5B, 7.21M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.7× Krida Jaringan Nusantara Tbk's market cap, and Krida Jaringan Nusantara Tbk is more actively traded (7.21M versus 96.7K). Which is the better fit depends on your goals.
| KJEN | OBAT | |
|---|---|---|
Market Cap | 61.5B | 167.37B |
Volume | 7.21M | 96.7K |
Lot | 72.09K | 967 |
Turnover | 878.11M | 23.82M |
Average Price | 121.8 | 246.34 |
Value | 878.11M | 23.82M |
Indicative Equilibrium Price | 122 | 248 |
Indicative Equilibrium Volume | 307 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Krida Jaringan Nusantara Tbk (the Company) was established in Jakarta based on the NotarialDeed No. 5 dated October 1, 1998 of Saal Bumela, S.H., Notary in Jakarta.
Read more on KJEN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →